Skip to main content
. 2020 Sep 2;52(8):1353–1365. doi: 10.1111/apt.16060

Table 4.

Incidence of gastrointestinal infections of special interest in patients with UC or CD

Parameter Ulcerative colitis (N = 894) Crohn's disease (N = 1349)
n (%) Incidence/1000 person‐years (95% CI) a n (%) Incidence/1000 person‐years (95% CI) a
Gastrointestinal infections of special interest 122 (13.6) 46.9 (38.3, 55.6) 162 (12.0) 46.1 (38.8, 53.4)
Abdominal and gastrointestinal infections (pathogen unspecified) b 92 (10.3) 34.9 (27.6, 42.3) 141 (10.5) 39.6 (32.9, 46.3)
Clostridium infections c 26 (2.9) 9.1 (5.6, 12.6) 21 (1.6) 5.4 (3.1, 7.8)
Campylobacter infections d 9 (1.0) 3.1 (1.1, 5.2) 8 (<1) 2.1 (0.6, 3.5)
Shigella infections e 0 0 1 (<1) 0.3 (0, 0.8)
Yersinia infections f 1 (<1) 0.3 (0, 1.0) 0 0
Bacterial infections (bacteria unspecified) g 0 0 1 (<1) 0.3 (0, 0.8)

Abbreviation: CI, confidence interval; MedDRA, Medical Dictionary for Regulatory Activities.

a

Time‐adjusted incidence rate per 1000 person‐years = (number of patients experiencing an adverse event of interest/total person time in years) × 1000.

b

MedDRA preferred terms: gastroenteritis, diarrhoea infectious, gastrointestinal infection, enteritis infectious, enterocolitis infectious and gastric infection.

c

MedDRA preferred terms: Clostridium difficile colitis, Clostridial infection and Clostridium colitis.

d

MedDRA preferred terms: Campylobacter gastroenteritis, Campylobacter intestinal infection and Campylobacter infection.

e

MedDRA preferred term gastroenteritis shigella.

f

MedDRA preferred term gastroenteritis yersinia.

g

Bacterial infections represent MedDRA preferred term gastroenteritis bacterial.